HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan.

Abstract
Identifying the risk factors responsible for lung cancer especially for nonsmokers is critical for both its prevention and treatment. Studies have linked the polymorphisms in N-acetyltransferases (NAT2), a key enzyme for metabolism of hydrocarbons, with lung cancer in Asian female nonsmokers. Since a high percentage of lung adenocarcinoma in Asian female nonsmokers contains activating hotspot mutations in epidermal growth factor receptors (EGFR), we hypothesized that NAT2 polymorphisms might represent a risk factor in lung cancer with EGFR mutations. We studied NAT polymorphisms in 117 nonsmall cell lung cancer (NSCLC) patients and in 119 healthy controls and EGFR hotspot mutations in exons 18-21 in 100 of the 117 patients using polymerase chain reactions. NAT2 fast acetylator genotypes were significantly associated with patients with lung cancer (P = 0.04, odds ratio (OR): 1.90, 95% confidence interval (CI): 1.02-3.57). Further analyses revealed that NAT2 fast acetylator genotypes were significantly associated with NSCLC with wildtype EGFR (P = 0.008, OR: 3.16, 95% CI: 1.31-7.63), but not with those with EGFR mutations (P = 0.40). Therefore, NAT2 fast acetylator genotypes are a potential risk factor especially for lung cancer with wildtype EGFR.
AuthorsChun-Nin Lee, Ming-Chih Yu, Kuan-Jen Bai, Jer-Hua Chang, Chia-Lang Fang, Han-Lin Hsu, Biing-Shiung Huang, Pei-Chih Lu, H Eugene Liu
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 64 Issue 1 Pg. 9-12 (Apr 2009) ISSN: 0169-5002 [Print] Ireland
PMID18706736 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • EGFR protein, human
  • ErbB Receptors
Topics
  • Acetylation
  • Adenocarcinoma (genetics, metabolism, secondary)
  • Adult
  • Aged
  • Aged, 80 and over
  • Arylamine N-Acetyltransferase (genetics, metabolism)
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, secondary)
  • Carcinoma, Squamous Cell (genetics, metabolism, secondary)
  • Case-Control Studies
  • ErbB Receptors (genetics, metabolism)
  • Female
  • Genotype
  • Humans
  • Lung (metabolism, pathology)
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Odds Ratio
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Genetic (genetics)
  • Prognosis
  • Risk Assessment
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: